Pre-Made Tanfanercept biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting TNF-¦Á receptor for drug discovery and mechanism of action (MOA) research
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Pre-Made Tanfanercept biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting TNF-¦Á receptor is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Tanfanercept (HBM9036) is a modified 19 kDa TNF receptor 1 fragment. It is used to relief the signs and symptoms of dry eye disease (DED) and with good eye permeability, strong TNF-¦Á neutralizing activity, high stability, and minor side effects.
| Products Name (INN Index) | Pre-Made Tanfanercept biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting TNF-¦Á receptor |
|---|---|
| INN Name | tanfanercept |
| Target | TNF-¦Á receptor |
| Format | Recombinant Protein |
| Derivation | Human |
| Species Reactivity | Human |
| CH1 Isotype | TBP-1 ( tumor necrosis factor (TNF) binding protein variant 1) |
| VD LC | TBP-1 ( tumor necrosis factor (TNF) binding protein variant 1) |
| Highest_Clin_Trial (Jan '20) | NA |
| Est. Status | NA |
| 100% SI Structure | NA |
| 99% SI Structure | NA |
| 95-98% SI Structure | NA |
| Year Proposed | NA |
| Year Recommended | NA |
| Companies | HanAll?BioPharma (Seoul South Korea) |
| Conditions Approved | NA |
| Conditions Active | NA |
| Conditions Discontinued | NA |
| Development Tech | NA |
| Previous Name | NA |
| Gm Offical Target Name | TNF-¦Á receptor |
| Package |
